C3 glomerulopathy: consensus report
File(s)C3 glomerulopathy consensus report.pdf (1.47 MB)
Published version
Author(s)
Type
Journal Article
Abstract
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.
Date Issued
2013-12-01
Date Acceptance
2013-06-20
Citation
Kidney International, 2013, 84 (6), pp.1079-1089
ISSN
0085-2538
Publisher
Elsevier
Start Page
1079
End Page
1089
Journal / Book Title
Kidney International
Volume
84
Issue
6
Copyright Statement
© 2013 International Society of Nephrology. Published by Elsevier Inc. This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Sponsor
Wellcome Trust
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327884000007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
098476/Z/12/Z
Subjects
Science & Technology
Life Sciences & Biomedicine
Urology & Nephrology
clinical immunology
clinical nephrology
complement
glomerulonephritis
immunology and pathology
DENSE-DEPOSIT DISEASE
COMPLEMENT FACTOR-H
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
PROVIDES INSIGHTS
ECULIZUMAB
MUTATION
CLASSIFICATION
DYSREGULATION
ACTIVATION
MECHANISM
Publication Status
Published
Date Publish Online
2015-12-16